Nutex Health (NUTX) | Financial Analysis & Statements
Nutex Health Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
151.7M
Gross Profit
46.1M
30.42%
Operating Income
30.9M
20.38%
Net Income
16.6M
10.95%
Balance Sheet Metrics
Total Assets
918.5M
Total Liabilities
495.1M
Shareholders Equity
423.4M
Debt to Equity
1.17
Cash Flow Metrics
Operating Cash Flow
92.8M
Free Cash Flow
69.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Nutex Health Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 875.3M | 479.9M | 247.6M | 219.3M | 331.5M |
| Cost of Goods Sold | 431.0M | 283.7M | 212.9M | 203.9M | 152.3M |
| Gross Profit | 444.3M | 196.3M | 34.8M | 15.4M | 179.3M |
| Gross Margin % | 50.8% | 40.9% | 14.0% | 7.0% | 54.1% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 168.7M | 58.5M | 36.1M | 20.0M | 5.5M |
| Other Operating Expenses | - | - | 217.3K | - | - |
| Total Operating Expenses | 168.7M | 58.5M | 36.3M | 20.0M | 5.5M |
| Operating Income | 275.6M | 137.8M | -1.5M | -4.6M | 173.8M |
| Operating Margin % | 31.5% | 28.7% | -0.6% | -2.1% | 52.4% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 22.2M | 19.9M | 16.3M | 12.5M | 6.2M |
| Other Non-Operating Income | -8.6M | -8.0M | -30.7M | -402.6M | 1.9M |
| Pre-tax Income | 244.8M | 109.8M | -48.5M | -419.6M | 169.5M |
| Income Tax | 64.4M | 15.0M | -5.1M | 13.1M | 965.7K |
| Effective Tax Rate % | 26.3% | 13.7% | 0.0% | 0.0% | 0.6% |
| Net Income | 180.4M | 94.8M | -43.4M | -432.7M | 168.5M |
| Net Margin % | 20.6% | 19.8% | -17.5% | -197.3% | 50.8% |
| Key Metrics | |||||
| EBITDA | 287.5M | 157.4M | 15.7M | 8.0M | 186.9M |
| EPS (Basic) | $11.13 | $10.25 | $-10.50 | $-100.50 | $30.90 |
| EPS (Diluted) | $10.48 | $9.71 | $-10.50 | $-100.50 | $30.90 |
| Basic Shares Outstanding | 6361427 | 5090651 | 4360630 | 4226671 | 4291577 |
| Diluted Shares Outstanding | 6361427 | 5090651 | 4360630 | 4226671 | 4291577 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Nutex Health Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 185.6M | 40.6M | 22.0M | 34.3M | 36.1M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 325.4M | 236.1M | 62.8M | 58.3M | 114.8M |
| Inventory | 2.9M | 2.8M | 3.4M | 3.5M | 2.8M |
| Other Current Assets | 24.7M | 10.0M | 2.7M | 1.9M | 323.3K |
| Total Current Assets | 538.8M | 292.5M | 90.8M | 98.0M | 154.0M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 287.0M | 284.2M | 223.1M | 243.0M | 113.3M |
| Goodwill | 49.1M | 43.4M | 54.6M | 55.2M | 3.0M |
| Intangible Assets | 21.2M | 15.5M | 20.5M | 21.2M | 682.6K |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 662.0K | 8.7M | 431.1K | 423.4K | 456.1K |
| Total Non-Current Assets | 379.7M | 362.8M | 307.4M | 333.8M | 240.6M |
| Total Assets | 918.5M | 655.3M | 398.2M | 431.8M | 394.7M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 49.0M | 10.4M | 25.3M | 27.5M | 17.7M |
| Short-term Debt | 23.3M | 27.7M | 20.1M | 21.1M | 13.2M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 157.9M | 154.2M | 58.3M | 54.9M | 37.7M |
| Non-Current Liabilities | |||||
| Long-term Debt | 328.1M | 312.6M | 255.7M | 246.1M | 165.4M |
| Deferred Tax Liabilities | 9.1M | 0 | 5.1M | 10.5M | 0 |
| Other Non-Current Liabilities | - | - | - | - | - |
| Total Non-Current Liabilities | 337.2M | 312.6M | 260.8M | 256.6M | 165.4M |
| Total Liabilities | 495.1M | 466.8M | 319.1M | 311.4M | 203.1M |
| Equity | |||||
| Common Stock | 7.0K | 5.5K | 676.7K | 650.2K | 592.8K |
| Retained Earnings | -286.2M | -357.0M | -409.1M | -363.3M | 102.3M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 423.4M | 188.5M | 79.1M | 120.3M | 191.6M |
| Key Metrics | |||||
| Total Debt | 351.4M | 340.3M | 275.8M | 267.2M | 178.6M |
| Working Capital | 380.9M | 138.3M | 32.5M | 43.1M | 116.3M |
Balance Sheet Composition
Nutex Health Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 180.4M | 94.8M | -43.4M | -432.7M | 168.5M |
| Depreciation & Amortization | 20.5M | 19.0M | 17.6M | 13.1M | 7.7M |
| Stock-Based Compensation | 117.0M | 16.6M | 2.8M | 189.6K | 0 |
| Working Capital Changes | -51.1M | -183.6M | -6.7M | 67.0M | -1.4M |
| Operating Cash Flow | 284.8M | -65.3M | -34.0M | -345.4M | 174.8M |
| Investing Activities | |||||
| Capital Expenditures | -2.5M | -2.3M | -9.5M | -14.6M | -36.9M |
| Acquisitions | 0 | -361.3K | -1.7M | 10.3M | -48.9K |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | 1.6M | - | - | - | - |
| Investing Cash Flow | -5.2M | -5.6M | -11.2M | -4.3M | -37.0M |
| Financing Activities | |||||
| Share Repurchases | -5.0M | - | - | - | - |
| Dividends Paid | -74.3M | -6.4M | -5.2M | -51.2M | -144.3M |
| Debt Issuance | 5.0M | 9.3M | 21.9M | 815.9K | 19.6M |
| Debt Repayment | -24.5M | -16.7M | -21.6M | -9.0M | -22.8M |
| Financing Cash Flow | -97.9M | -1.1M | -3.9M | -52.4M | -126.7M |
| Free Cash Flow | 245.6M | 20.8M | -8.2M | 36.0M | 136.5M |
| Net Change in Cash | 181.6M | -72.0M | -49.1M | -402.1M | 11.1M |
Cash Flow Trend
Nutex Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
10.34
Forward P/E
5.33
Price to Book
2.33
Price to Sales
0.88
PEG Ratio
5.33
Profitability Ratios
Profit Margin
8.09%
Operating Margin
97.52%
Return on Equity
58.94%
Return on Assets
31.18%
Financial Health
Current Ratio
3.41
Debt to Equity
82.99
Beta
2.02
Per Share Data
EPS (TTM)
$10.48
Book Value per Share
$46.49
Revenue per Share
$137.59
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| NUTX | 773.0M | 10.34 | 2.33 | 58.94% | 8.09% | 82.99 |
| HCA Healthcare | 106.0B | 16.86 | -38.44 | -244.82% | 8.97% | -17.57 |
| Tenet Healthcare | 16.5B | 12.17 | 3.88 | 27.02% | 6.60% | 160.79 |
| Surgery Partners | 1.9B | 2,956.00 | 1.09 | 2.76% | -2.35% | 114.51 |
| Pediatrix Medical | 1.9B | 11.88 | 2.16 | 20.28% | 8.64% | 73.29 |
| Astrana Health | 1.9B | 73.30 | 2.12 | 4.49% | 0.71% | 193.10 |
Financial data is updated regularly. All figures are in the company's reporting currency.






